Cannabis News Box

GW Pharmaceuticals gains approval from European Commission for EPIDYOLEX®

GW Pharmaceuticals gains approval from European Commission for EPIDYOLEX®

Bethan Rose Jenkins, Cannabis News Writer/Editorial

October 2, 2019

British drugs company GW Pharmaceuticals celebrated approval for its cannabinoid-based epilepsy medicine EPIDYOLEX® back in June 2018 in the United States.  Now, EPIDYOLEX has also gained approval from the European Commission, thus allowing the epilepsy treatment to be prescribed to diagnosed pat...

cannabis EU